172P Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2-positive locally advanced/metastatic gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJA): Primary efficacy and safety from the phase II single-arm DESTINY-Gastric06 (DG06) trial
| Autor: | Shen, L., Chen, P., Lu, J., Wan, Y., Zheng, Y., Ye, F., Yang, J., Liu, Y., Pan, H., Chen, H., Sun, M., Fan, Q., Yuan, Y., Chen, K., Sun, Z., Tian, H., Ye, X., Peng, Z. |
|---|---|
| Zdroj: | In Annals of Oncology November 2023 34 Supplement 4:S1542-S1543 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|